摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二氢-2-硫氧代-1H-苯并咪唑-4-羧酰胺 | 791591-51-0

中文名称
2,3-二氢-2-硫氧代-1H-苯并咪唑-4-羧酰胺
中文别名
——
英文名称
2-mercapto-4-carboxamidobenzimidazole
英文别名
2-mercapto-4-carboxamido-benzimidazole;1H-Benzimidazole-4-carboxamide, 2,3-dihydro-2-thioxo-;2-sulfanylidene-1,3-dihydrobenzimidazole-4-carboxamide
2,3-二氢-2-硫氧代-1H-苯并咪唑-4-羧酰胺化学式
CAS
791591-51-0
化学式
C8H7N3OS
mdl
——
分子量
193.229
InChiKey
LUKMEALKPUFVQI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    99.2
  • 氢给体数:
    3
  • 氢受体数:
    2

SDS

SDS:aa5e037db22a70a717e7a78837e5306d
查看

反应信息

  • 作为反应物:
    描述:
    2,3-二氢-2-硫氧代-1H-苯并咪唑-4-羧酰胺3-(bromomethyl)-2,5-dihydro-2,2,5,5-tetramethyl-1H-pyrrol-1-oxyl氢氧化钾 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以45%的产率得到2-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-ylmethylsulfanyl)-1H-benzimidazole-4-carboxylic acid amide
    参考文献:
    名称:
    [EN] NEW ALICYCLIC-AMINE-SUBSTITUTED 4-CARBOXAMIDO-BENZIMIDAZOLES AS PARP-INHIBITORS AND ANTIOXIDANTS
    [FR] NOUVEAUX 4-CARBOXAMIDO-BENZIMIDAZOLES ALICYCLIQUES SUBSTITUES PAR UNE AMINE UTILISES COMME INHIBITEURS DE PARP ET COMME ANTIOXYDANTS
    摘要:
    公式(I)的化合物及其药用或技术上可接受的酸加成盐——其中,在公式中,R1代表氢、C(1-4)烷基或C(1-4)烷氧基;R2代表氢、C(1-4)烷基、羧基、C(1-4)烷氧羰基、羧酰胺、芳基或杂芳基;R3代表氢、C(1-4)烷基、芳基亚甲基或芳基;Y代表一个价键、一个直链或支链的C(1-4)烯烃、一个羰基氨基-C(1-4)烯烃或一个-S-(CH2)m-基团,其中上述所有烯烃基团可能由一个芳基烯基团隔开;n代表零或整数1;m代表整数1、2或3;Q代表氢、羟基或氧自由基(0),或与相邻环的N原子一起形成一个+ N = O(氧肟酸)基团;Z代表一个单键或双键,以及它们的药用或技术上可用的盐,它们的制备方法以及它们作为PARP抑制剂和抗氧化剂的生物用途。
    公开号:
    WO2004096793A1
  • 作为产物:
    描述:
    二硫化碳2,3-二氨基苯甲酰胺sodium methylate 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 1.0h, 以46%的产率得到2,3-二氢-2-硫氧代-1H-苯并咪唑-4-羧酰胺
    参考文献:
    名称:
    New Poly(ADP-ribose) Polymerase-1 Inhibitors with Antioxidant Activity Based on 4-Carboxamidobenzimidazole-2-ylpyrroline and -tetrahydropyridine Nitroxides and Their Precursors
    摘要:
    4-Carboxamidobenzimidazoles were previously described as PARP inhibitor compounds. Here we report upon 4-carboxamido-1H-benzimidazoles substituted in the 2-position with nitroxides or their amine or hydroxylamine precursors. Among the new molecules, a highly active PARP inhibitor 4h (IC50 = 14 nM) was identified with antioxidant/radical scavenger activity. We concluded that in most cases sterically hindered amines are better PARP inhibitors than their oxidized form and structural changes in the 2-substituted 4-carboxamido-1H-benzimidazoles (such as N-substitution or changing the position of the carboxamide group) were detrimental to PARP inhibition activity but not to antioxidant activity. These results indicate the advantages of combining an antioxidant nitroxide or nitroxide precursor with a PARP inhibitor molecule to decrease or eliminate the deleterious processes initiated by reactive oxygen and reactive nitrogen species (ROS and RNS). The radical scavenging capability of 4h was demonstrated by EPR study of urine collected after drug administration.
    DOI:
    10.1021/jm801476y
点击查看最新优质反应信息

文献信息

  • [EN] NEW ALICYCLIC-AMINE-SUBSTITUTED 4-CARBOXAMIDO-BENZIMIDAZOLES AS PARP-INHIBITORS AND ANTIOXIDANTS<br/>[FR] NOUVEAUX 4-CARBOXAMIDO-BENZIMIDAZOLES ALICYCLIQUES SUBSTITUES PAR UNE AMINE UTILISES COMME INHIBITEURS DE PARP ET COMME ANTIOXYDANTS
    申请人:HIDEG KALMAN
    公开号:WO2004096793A1
    公开(公告)日:2004-11-11
    Compounds of the formula (I) and their pharmaceutically acceptable or technically applicable acid salts - where in the formula R1 represents hydrogen, C(1-4) alkyl or C(1-4) alkoxy R2 represents hydrogen, C(1-4) alkyl, carboxyl, C(1-4) alkoxycarbonyl, carboxamido,aryl or hetero-aryl R3 represents hydrogen, C(1-4) alkyl, aryl-methylene, or aryl, Y is a valency bond, a straight or branched chain C(1-4) alkene, a carbonyl-amino- C(1-4) alkene, or a -S- (CH2)m- group, where all alkene groups above may be spaced by an arylene group, n represents zero or the integer 1 m represents the integer 1, 2 or 3 Q represents hydrogen, hydroxyl or the oxygen radical (0) or together with the N atom of the adjacent ring forms a +N=O (oxoimmonium) group Z represents a single or double bond and their pharmaceutically acceptable or technically useful salts, processes for their preparation and their biological use as PARP inhibitors and antioxidants.
    公式(I)的化合物及其药用或技术上可接受的酸加成盐——其中,在公式中,R1代表氢、C(1-4)烷基或C(1-4)烷氧基;R2代表氢、C(1-4)烷基、羧基、C(1-4)烷氧羰基、羧酰胺、芳基或杂芳基;R3代表氢、C(1-4)烷基、芳基亚甲基或芳基;Y代表一个价键、一个直链或支链的C(1-4)烯烃、一个羰基氨基-C(1-4)烯烃或一个-S-(CH2)m-基团,其中上述所有烯烃基团可能由一个芳基烯基团隔开;n代表零或整数1;m代表整数1、2或3;Q代表氢、羟基或氧自由基(0),或与相邻环的N原子一起形成一个+ N = O(氧肟酸)基团;Z代表一个单键或双键,以及它们的药用或技术上可用的盐,它们的制备方法以及它们作为PARP抑制剂和抗氧化剂的生物用途。
  • New Poly(ADP-ribose) Polymerase-1 Inhibitors with Antioxidant Activity Based on 4-Carboxamidobenzimidazole-2-ylpyrroline and -tetrahydropyridine Nitroxides and Their Precursors
    作者:Tamás Kálai、Mária Balog、Alíz Szabó、Gergely Gulyás、József Jekő、Balázs Sümegi、Kálmán Hideg
    DOI:10.1021/jm801476y
    日期:2009.3.26
    4-Carboxamidobenzimidazoles were previously described as PARP inhibitor compounds. Here we report upon 4-carboxamido-1H-benzimidazoles substituted in the 2-position with nitroxides or their amine or hydroxylamine precursors. Among the new molecules, a highly active PARP inhibitor 4h (IC50 = 14 nM) was identified with antioxidant/radical scavenger activity. We concluded that in most cases sterically hindered amines are better PARP inhibitors than their oxidized form and structural changes in the 2-substituted 4-carboxamido-1H-benzimidazoles (such as N-substitution or changing the position of the carboxamide group) were detrimental to PARP inhibition activity but not to antioxidant activity. These results indicate the advantages of combining an antioxidant nitroxide or nitroxide precursor with a PARP inhibitor molecule to decrease or eliminate the deleterious processes initiated by reactive oxygen and reactive nitrogen species (ROS and RNS). The radical scavenging capability of 4h was demonstrated by EPR study of urine collected after drug administration.
查看更多